drugset / Trial / NCT03840226

The Impact of Magnesium on Exercise Tolerance, Quality of Life and Clinical Outcomes in Chronic Heart Failure Patients

NCT03840226

RandomizedParallel-groupSingle-blindTreatment

Summary

Magnesium supplementation could improve cardiac performance. Patients with chronic heart failure (CHF) are magnesium deficient and we hypothesized that 1 year supplementation of oral magnesium comparted to placebo will improve exercise duration time and quality of life.

Timeline

Start
2019-08-25
Primary completion
2026-01-01
Completion
2026-03-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Magnesium Oxide Small molecule 520 mg Oral